FDA Guidance · Pharmaceutical Quality

FDA guidance matters most when a Quality decision has to be explained later.

Use this page to navigate the FDA guidance and CGMP reference material most relevant to investigations, quality risk management, records, inspection readiness, and accountable Quality decisions.

Regulatory boundary: FDA guidance documents describe the Agency's current thinking and generally contain nonbinding recommendations unless specific regulatory requirements are cited. ComplianceWorxs' Four Lenses are a practical record-review framework, not an FDA requirement.

Start with the source

Use FDA's own guidance to establish the regulatory context.

Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical ProductionFinal Guidance · May 2022 → Q9(R1) Quality Risk ManagementFinal Guidance · May 2023 → Quality Systems Approach to Pharmaceutical CGMP RegulationsFDA Guidance · 2006 → CGMP Requirements — Records and Reports Q&AFDA CGMP reference → FDA Pharmaceutical Quality DocumentsSearch FDA's current quality guidance library →

Decision-specific authority

FDA guidance for OOS investigations, quality risk management, change control, and inspection readiness.

OOS investigations

Test whether the record explains the investigation path, root-cause conclusion, retest or invalidation rationale, batch impact, and accountable disposition.

Change control

Test whether the record shows the evidence, impact analysis, risk judgment, implementation conditions, and authorization behind the proposed change.

Inspection readiness

Test whether a later reviewer can retrieve the evidence, judgment, risk, and authorization behind consequential GMP decisions without reconstructing them from memory.

The practical question

Guidance establishes context. The organization still has to preserve its own decision basis.

A guidance document cannot supply the contemporaneous evidence, reasoning, residual uncertainty, or accountable authorization behind a specific site decision. Those elements have to exist in the organization's own controlled record.

ComplianceWorxs focuses on that decision layer: whether a qualified reviewer can understand why the organization acted as it did based on what was known at the time.

Apply the guidance to one record

Test whether one completed GMP decision can stand on its own.

The Decision Documentation Assessment examines the record through Evidence, Judgment, Risk, and Authorization without requiring confidential documents.

Assess one decision →See Decision Records →